Reid Hoffman Departs Microsoft Board to Pursue AI Drug Discovery Venture

Veteran investor Reid Hoffman is resigning from Microsoft's board after a decade of service. He will now dedicate his full attention to Manus, his artificial intelligence-focused drug discovery startup.

Reid Hoffman, a prominent figure in the technology and venture capital landscape, has announced his departure from the Microsoft board of directors. This decision marks the end of a ten-year tenure, during which he contributed to the technology giant's strategic direction.

Hoffman's departure is motivated by his desire to re-engage in 'founder mode.' He intends to concentrate his efforts on Manus, a startup he co-founded that leverages artificial intelligence for drug discovery. This pivot signifies a renewed commitment to entrepreneurial endeavors within the burgeoning field of AI-driven biotechnology.